Securities Code: 300143 Securities Abbreviation: Yingkang Life Announcement Number: 2026-003
Yingkang Life Technology Co., Ltd. Special Report on the Status of Raised Funds' Custody and Use for 2025
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or major omissions.
Yingkang Life Technology Co., Ltd. (hereinafter referred to as the "Company") Board of Directors, in accordance with the "Supervision Measures for the Management of Raised Funds of Listed Companies" issued by the China Securities Regulatory Commission and the "Normative Operation Guidelines for Companies Listed on the Shenzhen Stock Exchange No. 2 - GEM Companies" issued by the Shenzhen Stock Exchange, has compiled this special report on the custody and use of the Company's raised funds for 2025. The main content of the report is as follows:
I. Basic情况 of Raised Funds
(I) Basic情况 of Raised Funds from Non-public Offering of Shares in 2020
- Amount and Time of Receipt of Raised Funds
With the approval of the China Securities Regulatory Commission's "Approval for Yingkang Life Technology Co., Ltd. to Conduct Non-public Offering of Shares" (Securities Regulatory Permit [2020] No. 1030), the Company issued 96,312,746 ordinary shares (A shares) to a specific target, Qingdao Yingkang Medical Investment Co., Ltd., at a par value of RMB 1 per share and an issue price of RMB 7.61 per share. The total amount of raised funds from this issuance was RMB 732,939,997.06. After deducting issuance expenses of RMB 5,051,786.18 (excluding tax), the net amount of raised funds was RMB 727,888,210.88. These raised funds were all received on July 2, 2020. Xinyong Zhonghe Certified Public Accountants (Special General Partnership) audited the receipt of the raised funds and issued the "Capital Verification Report" with the number XYZH/2020GZA30231.
- Amount of Raised Funds Used in Previous Years
As of December 31, 2024, the Company had cumulatively used RMB 710,170,489.36 of raised funds (of which: RMB 5,678.32 was the cumulative bank handling fee paid in previous years), and the balance of raised funds was RMB 23,277,407.07.
- Use and Balance of Raised Funds During This Reporting Period
From January 1, 2025, to December 31, 2025 (hereinafter referred to as "This Reporting Period"), the Company actually used RMB 6,911,601.08 of raised funds (of which: RMB 656.00 was the bank handling fee paid during this reporting period). As of December 31, 2025, the balance of raised funds was RMB 16,429,586.76. The usage of raised funds is as follows:
| Item | Amount (RMB) |
|---|---|
| Total Raised Funds | 732,939,997.06 |
| Less: Various Issuance Expenses | 5,051,786.18 |
| Net Raised Funds | 727,888,210.88 |
| Less: Cumulative Raised Funds Invested | 717,075,756.12 |
| Of which: Raised Funds Invested This Period | 6,910,945.08 |
| Cumulative Bank Handling Fees Paid | 6,334.32 |
| Of which: Bank Handling Fees Paid This Period | 656.00 |
| Add: Cumulative Interest Income | 3,609,767.69 |
| Of which: Interest Income Received This Period | 63,780.77 |
| Cumulative Income from Wealth Management Products | 2,013,698.63 |
| Of which: Income from Wealth Management Products Received This Period | - |
| Balance of Raised Funds | 16,429,586.76 |
| Of which: Balance of Raised Funds Special Account | 16,429,586.76 |
(II) Basic情况 of Raised Funds from Non-public Offering of Shares to Specific Targets in 2022